Bacterial DNA and its consequences in patients with cirrhosis and culture-negative, non-neutrocytic ascites

Journal of Medical Microbiology

Volumn 57, Issue 12, 2008, Pages 1533-1538

  El Naggar, Mohammed Mahmoud ^a   Khalil, El Sayed Abdul Maksoud ^a   El Daker, Medhat Abdul Massih ^a   Salama, Mona Fouda ^a  

^a MANSOURA UNIVERSITY   (Egypt)

Author keywords

[No Author keywords available]

Indexed keywords

BACTERIAL DNA; TUMOR NECROSIS FACTOR ALPHA;

ADULT; ARTICLE; ASCITES; ASCITES FLUID; BACTERIAL PERITONITIS; BLOOD ANALYSIS; BLOOD LEVEL; CLINICAL ARTICLE; CLINICAL EXAMINATION; CLINICAL FEATURE; CONTROLLED STUDY; FEMALE; FOLLOW UP; HEPATORENAL SYNDROME; HOSPITAL ADMISSION; HUMAN; LIVER CIRRHOSIS; MALE; MORTALITY; NEUTROPHIL; PRIORITY JOURNAL; RISK FACTOR;

ADULT; ASCITES; ASCITIC FLUID; BACTERIAL INFECTIONS; BACTERIAL TRANSLOCATION; CELLS, CULTURED; DNA, BACTERIAL; FEMALE; HEPATORENAL SYNDROME; HUMANS; LIVER CIRRHOSIS; MALE; MIDDLE AGED; NEUTROPHILS; PERITONITIS; TUMOR NECROSIS FACTOR-ALPHA;

EID: 57749187850     PISSN: 00222615     EISSN: None     Source Type: Journal    
DOI: 10.1099/jmm.0.2008/001867-0     Document Type: Article

References (28)

1. Albillos, A., de La Hera, A., Gonzalez, M., Moya, J. L., Calleja, J. L., Monserrat, J., Ruiz-del-Arbol, L. & Alvarez-Mon, M. (2003). Increased lipopolysaccharide binding protein in cirrhotic patients with marked immune and hemodynamic derangement. Hepatology 37, 208-217.
2. Arroyo, V., Ginès, P., Gerbes, A. L., Dudley, F. J., Gentilini, P., Laffi, G., Reynolds, T. B., Ring-Larsen, H. & Schölmerich, J. (1996). Definition and diagnostic criteria of refractory ascites and hepatorenal syndrome in cirrhosis. International Ascites Club. Hepatology 23, 164-176.
3. Cirera, I., Bauer, T. M., Navasa, M., Vila, J., Grande, L., Taurá, P., Fuster, J., García-Valdecasas, J. C., Lacy, A. & other authors (2001). Bacterial translocation of enteric organisms in patients with cirrhosis. J Hepatol 34, 32-37.
4. Fernández, J., Navasa, M., Gómez, J., Colmenero, J., Vila, J., Arroyo, V. & Rodés, J. (2002). Bacterial infections in cirrhosis: epidemiological changes with invasive procedures and norfloxacin prophylaxis. Hepatology 35, 140-148.
5. Fiuza, C., Salcedo, M., Clemente, G. & Tellado, J. M. (2000). In vivo neutrophil dysfunction in cirrhotic patients with advanced liver disease. J Infect Dis 182, 526-533.
6. Francés, R., Muñoz, C., Zapater, P., Uceda, F., Gascón, I., Pascual, S., Pérez-Mateo, M. & Such, J. (2004a). Bacterial DNA activates cell mediated immune response and nitric oxide overproduction in peritoneal macrophages from patients with cirrhosis and ascites. Gut 53, 860-864.
7. Francés, R., Benlloch, S., Zapater, P., González, J. M., Lozano, B., Muñoz, C., Pascual, S., Casellas, J. A., Uceda, F. & other authors (2004b). A sequential study of serum bacterial DNA in patients with advanced cirrhosis and ascites. Hepatology 39, 484-491.
8. Francés, R., Rodríguez, E., Muñoz, C., Zapater, P., De la Sen, M. L., Ndongo, M., Pérez-Mateo, M. & Such, J. (2005). Intracellular cytokine expression in peritoneal monocyte/macrophages obtained from patients with cirrhosis and presence of bacterial DNA. Eur J Gostroenterol Hepatol 17, 45-51.
9. Genescà, J., Martí, R., Rojo, F., Campos, F., Peribáñez, V., Gónzalez, A., Castells, L., Ruiz-Marcellán, C., Margarit, C. & other authors (2003). Increased tumor necrosis factor alpha production in mesenteric lymph nodes of cirrhotic patients with ascites. Gut 52, 1054-1059.
10. Ginès, P., Guevara, M., Arroyo, V. & Rodés, J. (2003). Hepatorenal syndrome. Lancet 362, 1819-1827.
11. Guarner, C. & Soriano, G. (1997). Spontaneous bacterial peritonitis. Semin Liver Dis 17, 203-217.
12. Lipford, G. B., Sparwasser, T., Bauer, M., Zimmermann, S., Koch, E. S., Heeg, K. & Wagner, H. (1997). Immunostimulatory DNA: sequence-dependent production of potentially harmful or useful cytokines. Eur J Immunol 27, 3420-3426.
13. MacMicking, J., Xie, Q. W. & Nathan, C. (1997). Nitric oxide and macrophage function. Annu Rev Immunol 15, 323-350.
14. Navasa, M., Follo, A., Filella, X., Jiménez, W., Francitorra, A., Planas, R., Rimola, A., Arroyo, V. & Rodés, J. (1998). Tumor necrosis factor and interleukin-6 in spontaneous bacterial peritonitis in cirrhosis: relationship with the development of renal impairment and mortality. Hepatology 27, 1227-1232.
15. Rangel-Frausto, M. S., Pittet, D., Costigan, M., Hwang, T., Davis, C. S. & Wenzel, R. P. (1995). The natural history of the systemic inflammatory response syndrome (SIRS). A prospective study. JAMA 273, 117-123.
16. Ruiz-del-Arbol, L., Urman, J., Fernández, J., González, M., Navasa, M., Monescillo, A., Albillos, A., Jiménez, W. & Arroyo, V. (2003). Systemic, renal and hepatic hemodynamic derangement in cirrhotic patients with spontaneous bacterial peritonitis. Hepatology 38, 1210-1218.
17. Runyon, B. A. (1986). Paracentesis of ascitic fluid: a safe procedure. Arch Intern Med 146, 2259-2261.
18. Runyon, B. A. (1988). Patients with deficient ascitic fluid opsonic activity are predisposed to spontaneous bacterial peritonitis. Hepatology 8, 632-635.
19. Runyon, B. A. & Hoefs, J. C. (1984). Culture-negative neutrocytic ascites: a variant of spontaneous bacterial peritonitis. Hepatology 4, 1209-1211.
20. Runyon, B. A., Squier, S. & Borzio, M. (1994). Translocation of gut bacteria in rats with cirrhosis to mesenteric lymph nodes partially explains the pathogenesis of spontaneous bacterial peritonitis. J Hepatol 21, 792-796.
21. Sakrak, O., Akpinar, M., Bedirli, A., Akyurek, N. & Aritas, Y. (2003). Short and long-term effects of bacterial translocation due to obstructive jaundice on liver damage. Hepatogastroenterology 50, 1542-1546.
22. Such, J. & Runyon, B. A. (1998). Spontaneous bacterial peritonitis. Clin Infect Dis 27, 669-674.
23. Such, J., Hillebrand, D. J., Guarner, C., Berk, L., Zapater, P., Westengard, J., Peralta, C., Soriano, G., Pappas, J. & Runyon, B. A. (2001). Tumor necrosis factor-alpha, interleukin-6 and nitric oxide in sterile ascitic fluid and serum from patients with cirrhosis who subsequently develop ascitic fluid infection. Dig Dis Sci 46, 2360-2366.
24. Such, J., Francés, R. & Pérez-Mateo, M. (2002a). Nitric oxide in patients with cirrhosis and bacterial infections. Metab Brain Dis 17, 303-309.
25. Such, J., Francés, R., Muñoz, C., Zapater, P., Casellas, J. A., Cifuentes, A., Rodriguez-Valera, F., Pascual, S., Sola-Vera, J. & other authors (2002b). Detection and identification of bacterial DNA in patients with cirrhosis and culture-negative, non-neutrocyticascites. Hepatology 36, 135-141.
26. Wagner, H. (2002). Interactions between bacterial CpG-DNA and TLR9 bridge innate and adaptive immunity. Curr Opin Microbiol 5, 62-69.
27. Wiest, R. & Rath, H. C. (2003). Gastrointestinal disorders of the critically ill. Bacterial translocation in the gut. Best Pract Res Clin Gastroenterol 17, 397-425.
28. Wiest, R., Das, S., Cadelina, G., Garcia-Tsao, G., Milstien, S. & Groszmann, R. J. (1999). Bacterial translocation in cirrhotic rats stimulates eNOS derived NO production and impairs mesenteric vascular contractility. J Clin Invest 104, 1223-1233.